Načítá se...
PERSPECTIVES ON THE OPTIMAL GENETICALLY-ENGINEERED PIG IN 2018 FOR INITIAL CLINICAL TRIALS OF KIDNEY OR HEART XENOTRANSPLANTATION
For a clinical trial today, what might realistically be the optimal pig among those currently available? Deletion of expression of the 3 pig carbohydrate antigens against which humans have natural (preformed) antibodies (triple-knockout [TKO] pigs) should form the basis of any clinical trial. Howeve...
Uloženo v:
| Vydáno v: | Transplantation |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6249080/ https://ncbi.nlm.nih.gov/pubmed/30247446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000002443 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|